Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure


A Safety and Efficacy Study of Blood Pressure Control in Acute Heart Failure - A Pilot Study (PRONTO)




The purpose of this study is to evaluate the efficacy and safety of intravenous (IV) clevidipine as compared with standard of care IV antihypertensive agents for blood pressure (BP) lowering in patients with acute heart failure and elevated BP.

Study Status: Completed


Condition Intervention Phase
Heart Failure
Drug: Clevidipine butyrate injectable emulsion
Drug: standard of care IV antihypertensive treatment
Phase 3

Verified by The Medicines Company June, 2012

Sponsored by: The Medicines Company
Information provided by: The Medicines Company identifier: NCT00803634

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

The Cleveland Clinic
Cleveland, Ohio 44195
United States

W. Frank Peacock, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit
  Information obtained from on
Link to the current record.

Cleveland Clinic Mobile Site